a viable bone matrix for bone repair and regeneration (available exclusively from Stryker). Given its expertise in the commercialization of cryopreserved cell and tissue therapies, Osiris ...

The global cell cryopreservation market revenue was around US$ 12.5 billion in 2023 and is estimated to reach US$ 76.4 billion by 2032, growing at a compound annual growth rate (CAGR) of 22.2% during ...